Group | Blank group | Model group | Methotrexate group | RAR group | Vinegar-processed RAR group |
---|---|---|---|---|---|
Dose (mg/kg) | 0 | 0 | 5 | 336 | 336 |
0.5 h Swell (mm) | 4.32 ± 0.50 | 7.79 ± 0.84 | 6.83 ± 0.95 | 7.22 ± 0.45 | 7.13 ± 0.55 |
0.5 h Inhibition Rate (%) | 0% | 80.32% | 58.10% | 67.13% | 65.05% |
1.0 h Swell (mm) | 4.92 ± 0. 83 | 8.42 ± 0.56 | 7.45 ± 0.42 | 7.41 ± 0.99 | 7.02 ± 0.23 |
1.0 h Inhibition Rate (%) | 0% | 71.13% | 51.42% | 50.61% | 42.68% |
2.0 h Swell (mm) | 5.21 ± 0. 46 | 8.57 ± 0.28 | 7.56 ± 0.25 | 6.87 ± 0.36* | 6.56 ± 0.41* |
2.0 h Inhibition Rate (%) | 0% | 64.49% | 45.11% | 31.86% | 25.91% |
3.0 h Swell (mm) | 5.13 ± 0.92 | 8.32 ± 0.39 | 6.59 ± 0.68* | 6.32 ± 0.26** | 6.28 ± 0.37** |
3.0 h Inhibition Rate (%) | 0% | 62.18% | 28.46% | 23.30% | 22.42% |
4.0 h Swell (mm) | 4.97 ± 0. 71 | 7.95 ± 0.17 | 6.33 ± 0.48** | 6.08 ± 0.78** | 6.02 ± 0.21** |
4.0 h Inhibition Rate (%) | 0% | 60.00% | 27.36% | 22.33% | 21.13% |
6.0 h Swell (mm) | 4.33 ± 0. 19 | 7.21 ± 0.44 | 5.02 ± 0.74** | 5.30 ± 0.59** | 4.98 ± 0.29** |
6.0 h Inhibition Rate (%) | 0% | 66.51% | 15.94% | 22.40% | 15.01% |